Von Willebrand factor and platelet adhesiveness

Area of Science:

• Hematology
• Coagulation Science
• In Vitro Diagnostics

Background:

• Von Willebrand factor (vWF) is crucial for platelet adhesion and is deficient in von Willebrand disease.
• Accurate in vitro assays are needed to assess vWF activity and evaluate therapeutic agents.
• Current methods may not fully capture the functional aspects of vWF in platelet aggregation.

Purpose of the Study:

• To adapt and validate a modified Salzman method for quantifying von Willebrand factor activity in vitro.
• To assess the corrective effect of plasma components and antihaemophilic factor (AHF) concentrates on platelet adhesiveness.
• To compare in vitro assay results with in vivo observations for AHF concentrates.

Main Methods:

• A modified Salzman's method was employed, utilizing coated beads to measure platelet adhesiveness.
• Beads were pre-coated with normal plasma, hemophilic plasma, cryoprecipitate, or von Willebrand plasma.
• The effect of antihaemophilic factor (AHF) concentrates on platelet adhesiveness was evaluated and compared to in vivo data.

Main Results:

• Coating beads with normal plasma or cryoprecipitate significantly increased platelet adhesiveness in von Willebrand's disease.
• Von Willebrand plasma alone did not demonstrate a corrective effect on platelet adhesiveness.
• Results from AHF concentrate studies showed potential correlation between in vitro findings and in vivo efficacy.

Conclusions:

• The modified Salzman method provides a viable in vitro assay for assessing von Willebrand factor functionality.
• Normal plasma and cryoprecipitate contain factors that can restore normal platelet adhesiveness in vitro.
• This assay may serve as a valuable tool for evaluating the efficacy of vWF-containing therapies.